Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Association of melatonin receptor 1 B gene (rs10830963 and rs9192552) polymorphısm with adolescent obesity and related comorbidities in Turkey.

Çöl N, Nacak M, Araz M.

J Int Med Res. 2018 Jan 1:300060518772224. doi: 10.1177/0300060518772224. [Epub ahead of print]

PMID:
29726288
2.

Changing Patients' Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial.

Bailey RA, Shillington AC, Harshaw Q, Funnell MM, VanWingen J, Col N.

Diabetes Ther. 2018 Apr;9(2):803-814. doi: 10.1007/s13300-018-0391-7. Epub 2018 Mar 13.

PMID:
29536425
3.

Prevalence of hypertension determined by ambulatory blood pressure monitoring (ABPM) and body composition in long-term survivors of childhood cancer.

Guler E, Col N, Buyukcelik M, Balat A.

Pediatr Hematol Oncol. 2018 Feb;35(1):1-10. doi: 10.1080/08880018.2018.1425784. Epub 2018 Mar 12.

PMID:
29528260
4.

Adolescent obesity and the role of the fat mass and obesity-associated gene polymorphism.

Çöl N, Demircioğlu-Kiliç B, Nacak M, Araz M.

Clin Invest Med. 2017 Dec 17;40(6):E235-E242. doi: 10.25011/cim.v40i6.29124.

PMID:
29256389
5.

Uteroglobin gene polymorphism (G38A) may be a risk factor in childhood idiopathic nephrotic syndrome.

Demircioglu Kılıc B, Buyukcelik M, Oguzkan Balcı S, Pehlivan S, Kul S, Col N, Balat A.

Pediatr Nephrol. 2018 Feb;33(2):295-303. doi: 10.1007/s00467-017-3800-7. Epub 2017 Sep 30.

PMID:
28965242
6.

Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals.

Col NF, Solomon AJ, Springmann V, Garbin CP, Ionete C, Pbert L, Alvarez E, Tierman B, Hopson A, Kutz C, Berrios Morales I, Griffin C, Phillips G, Ngo LH.

Med Decis Making. 2018 Jan;38(1):44-55. doi: 10.1177/0272989X17724434. Epub 2017 Aug 14.

7.

What Families Need and Physicians Deliver: Contrasting Communication Preferences Between Surrogate Decision-Makers and Physicians During Outcome Prognostication in Critically Ill TBI Patients.

Quinn T, Moskowitz J, Khan MW, Shutter L, Goldberg R, Col N, Mazor KM, Muehlschlegel S.

Neurocrit Care. 2017 Oct;27(2):154-162. doi: 10.1007/s12028-017-0427-2.

PMID:
28685395
8.

A multicentre evaluation of an opioid patient-provider agreement.

Pergolizzi JV, Curro FA, Col N, Ghods MP, Vena D, Taylor R, Naftolin F, LeQuang JA.

Postgrad Med J. 2017 Oct;93(1104):613-617. doi: 10.1136/postgradmedj-2016-134607. Epub 2017 May 10.

PMID:
28490546
9.

Patient-Reported Usability of Positive Airway Pressure Equipment Is Associated With Adherence in Older Adults.

Fung CH, Martin JL, Hays RD, Patterson ES, Aysola R, Col N, Mitchell MN, Truong C, Dzierzewski JM, Jouldjian S, Song Y, Rodriguez JC, Josephson K, Alessi C.

Sleep. 2017 Mar 1;40(3). doi: 10.1093/sleep/zsx007.

10.

Kidney Disease Profile of Syrian Refugee Children.

Akbalik Kara M, Demircioglu Kilic B, Col N, Ozcelik AA, Buyukcelik M, Balat A.

Iran J Kidney Dis. 2017 Mar;11(2):109-114.

11.

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.

Chlebowski RT, Pan K, Col NF.

Breast Cancer Res Treat. 2017 Jan;161(2):185-190. doi: 10.1007/s10549-016-4024-4. Epub 2016 Oct 26. Review.

PMID:
27785653
12.

Perceived Effectiveness, Self-efficacy, and Social Support for Oral Appliance Therapy Among Older Veterans With Obstructive Sleep Apnea.

Carballo NJ, Alessi CA, Martin JL, Mitchell MN, Hays RD, Col N, Patterson ES, Jouldjian S, Josephson K, Fung CH.

Clin Ther. 2016 Nov;38(11):2407-2415. doi: 10.1016/j.clinthera.2016.09.008. Epub 2016 Oct 15.

13.

Impact and Feasibility of Personalized Decision Support for Older Patients with Diabetes: A Pilot Randomized Trial.

Huang ES, Nathan AG, Cooper JM, Lee SM, Shin N, John PM, Dale W, Col NF, Meltzer DO, Chin MH.

Med Decis Making. 2017 Jul;37(5):611-617. doi: 10.1177/0272989X16654142. Epub 2016 Jun 16.

14.

Patient-Provider Communication With Older Adults About Sleep Apnea Diagnosis and Treatment.

Fung CH, Alessi C, Truong C, Josephson K, Hays RD, Col N, Patterson ES, Martin JL.

Behav Sleep Med. 2017 Nov-Dec;15(6):423-437. doi: 10.1080/15402002.2016.1150278. Epub 2016 May 4.

15.

Effects of Design Features of Explicit Values Clarification Methods: A Systematic Review.

Witteman HO, Gavaruzzi T, Scherer LD, Pieterse AH, Fuhrel-Forbis A, Chipenda Dansokho S, Exe N, Kahn VC, Feldman-Stewart D, Col NF, Turgeon AF, Fagerlin A.

Med Decis Making. 2016 Aug;36(6):760-76. doi: 10.1177/0272989X16634085. Epub 2016 Apr 4. Review.

PMID:
27044883
16.

Design Features of Explicit Values Clarification Methods: A Systematic Review.

Witteman HO, Scherer LD, Gavaruzzi T, Pieterse AH, Fuhrel-Forbis A, Chipenda Dansokho S, Exe N, Kahn VC, Feldman-Stewart D, Col NF, Turgeon AF, Fagerlin A.

Med Decis Making. 2016 May;36(4):453-71. doi: 10.1177/0272989X15626397. Epub 2016 Jan 29. Review.

PMID:
26826032
17.

Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict.

Bailey RA, Pfeifer M, Shillington AC, Harshaw Q, Funnell MM, VanWingen J, Col N.

BMC Health Serv Res. 2016 Jan 14;16:10. doi: 10.1186/s12913-016-1262-4.

18.

Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.

Chlebowski RT, Haque R, Hedlin H, Col N, Paskett E, Manson JE, Kubo JT, Johnson KC, Wactawski-Wende J, Pan K, Anderson G.

Breast Cancer Res Treat. 2015 Dec;154(3):609-16. doi: 10.1007/s10549-015-3647-1. Epub 2015 Nov 24.

PMID:
26602222
19.

Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.

Kaiser K, Cheng WY, Jensen S, Clayman ML, Thappa A, Schwiep F, Chawla A, Goldberger JJ, Col N, Schein J.

Curr Med Res Opin. 2015 Dec;31(12):2261-72. doi: 10.1185/03007995.2015.1096767. Epub 2015 Oct 22.

PMID:
26390360
20.

Development of a patient decision aid for type 2 diabetes mellitus for patients not achieving glycemic control on metformin alone.

Shillington AC, Col N, Bailey RA, Jewell MA.

Patient Prefer Adherence. 2015 Apr 30;9:609-17. doi: 10.2147/PPA.S82555. eCollection 2015.

21.

Decision Aids and Shared Decision-Making in Neurocritical Care: An Unmet Need in Our NeuroICUs.

Muehlschlegel S, Shutter L, Col N, Goldberg R.

Neurocrit Care. 2015 Aug;23(1):127-30. doi: 10.1007/s12028-014-0097-2.

22.

Decision aids for people facing health treatment or screening decisions.

Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L, Wu JH.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD001431. doi: 10.1002/14651858.CD001431.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431.

PMID:
24470076
23.

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.

Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM.

J Clin Oncol. 2013 Aug 10;31(23):2942-62. doi: 10.1200/JCO.2013.49.3122. Epub 2013 Jul 8. Review. Erratum in: J Clin Oncol. 2013 Dec 1;31(34):4383.

PMID:
23835710
24.

Clarifying values: an updated review.

Fagerlin A, Pignone M, Abhyankar P, Col N, Feldman-Stewart D, Gavaruzzi T, Kryworuchko J, Levin CA, Pieterse AH, Reyna V, Stiggelbout A, Scherer LD, Wills C, Witteman HO.

BMC Med Inform Decis Mak. 2013;13 Suppl 2:S8. doi: 10.1186/1472-6947-13-S2-S8. Epub 2013 Nov 29. Review.

25.

Balancing the presentation of information and options in patient decision aids: an updated review.

Abhyankar P, Volk RJ, Blumenthal-Barby J, Bravo P, Buchholz A, Ozanne E, Vidal DC, Col N, Stalmeier P.

BMC Med Inform Decis Mak. 2013;13 Suppl 2:S6. doi: 10.1186/1472-6947-13-S2-S6. Epub 2013 Nov 29. Review.

26.

Metformin and breast cancer risk: a meta-analysis and critical literature review.

Col NF, Ochs L, Springmann V, Aragaki AK, Chlebowski RT.

Breast Cancer Res Treat. 2012 Oct;135(3):639-46. doi: 10.1007/s10549-012-2170-x. Epub 2012 Jul 31. Review.

PMID:
22847511
27.

Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors.

Chlebowski RT, Col N.

Breast J. 2012 Jul-Aug;18(4):299-302. doi: 10.1111/j.1524-4741.2012.01267.x. Epub 2012 Jun 11.

PMID:
22681627
28.

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.

Ganz PA, Barry JM, Burke W, Col NF, Corso PS, Dodson E, Hammond ME, Kogan BA, Lynch CF, Newcomer L, Seifter EJ, Tooze JA, Viswanath K, Wessells H.

Ann Intern Med. 2012 Apr 17;156(8):591-5. doi: 10.7326/0003-4819-156-8-201204170-00401. Epub 2012 Feb 20. No abstract available.

29.

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

Meadows ES, Mitchell BD, Bolge SC, Johnston JA, Col NF.

BMC Womens Health. 2012 Jan 6;12:1. doi: 10.1186/1472-6874-12-1.

30.

Bisphosphonates and breast cancer incidence and recurrence.

Chlebowski RT, Col N.

Breast Dis. 2011;33(2):93-101. doi: 10.3233/BD-2010-0324. Review.

PMID:
22142660
31.

NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer.

Ganz PA, Barry JM, Burke W, Col NF, Corso PS, Dodson E, Hammond ME, Kogan BA, Lynch CF, Newcomer L, Seifter EJ, Tooze JA, Viswanath KV, Wessells H.

NIH Consens State Sci Statements. 2011 Dec 5-7;28(1):1-27.

PMID:
23392076
32.

Interprofessional education about shared decision making for patients in primary care settings.

Col N, Bozzuto L, Kirkegaard P, Koelewijn-van Loon M, Majeed H, Jen Ng C, Pacheco-Huergo V.

J Interprof Care. 2011 Nov;25(6):409-15. doi: 10.3109/13561820.2011.619071.

PMID:
22011026
33.

Decision aids for people facing health treatment or screening decisions.

Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD001431. doi: 10.1002/14651858.CD001431.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD001431.

PMID:
21975733
34.

Bisphosphonates and breast cancer prevention.

Chlebowski RT, Col N.

Anticancer Agents Med Chem. 2012 Feb;12(2):144-50. Review.

PMID:
21864227
35.

Comments and response on the USPSTF recommendation on screening for breast cancer.

Col NF, Hansen MH, Fischhoff B, Pauker SG.

Ann Intern Med. 2010 Apr 20;152(8):542; author reply 543-4. doi: 10.7326/0003-4819-152-8-201004200-00206. Epub 2010 Feb 15. No abstract available.

PMID:
20157100
36.

Decision aids for people facing health treatment or screening decisions.

O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, Entwistle VA, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001431. doi: 10.1002/14651858.CD001431.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(10):CD001431.

PMID:
19588325
37.

Measuring the impact of menopausal symptoms on quality of life: methodological considerations.

Col NF, Haskins AE, Ewan-Whyte CJ.

Menopause. 2009 Sep-Oct;16(5):843-5. doi: 10.1097/gme.0b013e3181b15030. Review. No abstract available.

PMID:
19564804
38.

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

J Clin Oncol. 2009 Jul 1;27(19):3235-58. doi: 10.1200/JCO.2008.20.5179. Epub 2009 May 26.

39.

In the clinic. Menopause.

Col NF, Fairfield KM, Ewan-Whyte C, Miller H.

Ann Intern Med. 2009 Apr 7;150(7):ITC4-1-15; quiz ITC4-16,. Review. No abstract available.

PMID:
19349628
40.

Questioning the accuracy of a recent review of osteoporosis medications.

Kuhl LN, Ettinger B, Rosen CJ, Col NF.

Ann Intern Med. 2009 Mar 17;150(6):423-4; author reply 424-5. No abstract available.

PMID:
19293078
41.

Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi).

Elwyn G, O'Connor AM, Bennett C, Newcombe RG, Politi M, Durand MA, Drake E, Joseph-Williams N, Khangura S, Saarimaki A, Sivell S, Stiel M, Bernstein SJ, Col N, Coulter A, Eden K, Härter M, Rovner MH, Moumjid N, Stacey D, Thomson R, Whelan T, van der Weijden T, Edwards A.

PLoS One. 2009;4(3):e4705. doi: 10.1371/journal.pone.0004705. Epub 2009 Mar 4.

42.

Duration of vasomotor symptoms in middle-aged women: a longitudinal study.

Col NF, Guthrie JR, Politi M, Dennerstein L.

Menopause. 2009 May-Jun;16(3):453-7. doi: 10.1097/gme.0b013e31818d414e.

PMID:
19188852
43.

Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.

Chlebowski RT, Col N.

J Natl Cancer Inst. 2008 Sep 17;100(18):1331-2; author reply 132-3. doi: 10.1093/jnci/djn272. Epub 2008 Sep 9. No abstract available.

PMID:
18780870
44.

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.

Col NF, Chlebowski RT.

Menopause. 2008 Jul-Aug;15(4 Suppl):804-9. doi: 10.1097/gme.0b013e31817e5cce. Review.

PMID:
18596602
45.

Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis.

Politi MC, Schleinitz MD, Col NF.

J Gen Intern Med. 2008 Sep;23(9):1507-13. doi: 10.1007/s11606-008-0655-4. Epub 2008 Jun 3.

46.

Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?

Hohenhaus MH, McGarry KA, Col NF.

Drugs. 2007;67(16):2311-21. Review.

PMID:
17983253
47.

Can computerized decision support help patients make complex treatment decisions? A randomized controlled trial of an individualized menopause decision aid.

Col NF, Ngo L, Fortin JM, Goldberg RJ, O'Connor AM.

Med Decis Making. 2007 Sep-Oct;27(5):585-98. Epub 2007 Sep 14.

PMID:
17873260
48.

Communicating the uncertainty of harms and benefits of medical interventions.

Politi MC, Han PK, Col NF.

Med Decis Making. 2007 Sep-Oct;27(5):681-95. Epub 2007 Sep 14. Review.

PMID:
17873256
49.

Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis.

O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR.

Med Decis Making. 2007 Sep-Oct;27(5):554-74. Epub 2007 Sep 14. Review.

PMID:
17873255
50.

A latent class typology of young women smokers.

Rose JS, Chassin L, Presson C, Sherman SJ, Stein MD, Col N.

Addiction. 2007 Aug;102(8):1310-9.

PMID:
17624981

Supplemental Content

Support Center